| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP00089 |
|
161308-36-7 |
N-(2-Hydroxyethyl)piperazine-N'-(4-butanesulfonic acid) - 99% |
0 | C10H22N2O4S | |
| CP00088 |
|
124763-51-5 |
Bis-TRIS hydrochloride - 99% |
0 | C8H20ClNO5 | |
| CP00087 |
|
70331-82-7 |
N-(Tris(hydroxymethyl)methyl)-2-aminoethanesulfonicacidsodiumsalt - 99% |
3千克 | C6H14NNaO6S | |
| CP00086 |
![3-[N-Tris(hydroxymethyl)methylamino]-2-hydroxypropanesulfonic acid sodium salt](/image/9048)
|
105140-25-8 |
3-[N-Tris(hydroxymethyl)methylamino]-2-hydroxypropanesulfonic acid sodium salt - 99% |
0 | C7H16NNaO7S | |
| CP00085 |
|
68399-81-5 |
TAPSO - 99% |
0 | C7H17NO7S | |
| CP00084 |
|
108321-07-9 |
Piperazine-N,N'-bis(2-hydroxypropanesulphonic acid) disodium salt - 98% |
0 | C10H20N2Na2O8S2 | |
| CP00083 |
|
108321-08-0 |
Piperazine-N,N'-bis(2-hydroxypropanesulfonic acid) sesquisodium salt - 98% |
0 | C10H23N2NaO8S2 | |
| CP00082 |
|
68189-43-5 |
POPSO - 98% |
0 | C16H33N4Na3O12S4 | |
| CP00081 |
|
76836-02-7 |
Disodium piperazine-1,4-diethanesulphonate - 98% |
0 | C8H16N2Na2O6S2 | |
| CP00080 |
|
100037-69-2 |
PIPES sesquisodium salt - 98% |
0 | C16H33N4Na3O12S4 | |
| CP00079 |
|
61931-81-5 |
cis-3-Hexenyl lactate - 98% |
0 | C9H16O3 | |
| CP00078 |
|
230615-51-7 |
2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine - 98% |
0 | C13H12F3NO | |
| CP00076 |
|
22373-09-7 |
Calcium Arabonate; Calcium-D-Arabinoate; D-Arabinonic acid calcium salt - 98% |
0 | C5H12CaO6 | |
| CP00075 |
|
127852-28-2 |
(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol - 99% |
0 | C10H8F6O | |
| CP00074 |
|
8000-48-4 |
Eucalyptusoil - 98% |
0 | C10H18O | |
| CP00073 |
|
1317-80-2 |
Rutile - 98% |
0 | O2Ti | |
| CP00072 |
|
9006-65-9 |
Dimethicone - 98% |
0 | C6H18OSi2 | |
| CP00071 |
|
875356-43-7 |
Secukinuma - 98% |
0 | — | |
| CP00070 |
|
945721-28-8 |
Daratumumab - 98% |
0 | — | |
| CP00069 |
|
242138-07-4 |
Omalizumab - 98% |
0 | — | |
